Brainstorm Cell Therapeutics reported $12.38M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Biogen USD 3.9B 18.7M Sep/2026
Brainstorm Cell Therapeutics USD 12.38M 621K Jun/2026
Cipla INR 69.77B 366.6M Sep/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.63M 596K Jun/2026
CSL USD 4.61B 207M Dec/2025
Cytokinetics USD 353.42M 171.99M Sep/2026
Gilead Sciences USD 12B 982M Sep/2026
Grifols EUR 2.37B 156.97M Dec/2025
Halozyme Therapeutics USD 476.09M 131.65M Sep/2026
Mesoblast USD 81.11M 46.96M Jun/2026